ACONW Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 Jun 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.01% compare to its pairs and should correct upwards.

Stats
Today's Volume	2 445
Average Volume	0
Market Cap	2.44M
EPS	$-0.440 ( Q1 \| 2024-05-15 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0100 (Sector) 42.63 (Industry) 31.08
ATR14	$0 (0.00%)

ACONW 13.35%

AKLI -0.07%

BEATW -10.00%

BFRG -1.14%

BFRGW -12.15%

BTSG 4.99%

BTSGU 5.87%

CCLD -3.52%

CCLDO 3.02%

CCLDP -0.98%

CERN 0.00%

CHNG 0.26%

CMAXW -6.00%

ETAO -31.79%

EUDA -26.38%

EUDAW 16.53%

GEHC -1.14%

GEHCV -4.08%

INOV 0.14%

KERNW 0.00%

LIFW -2.17%

MGRX -5.88%

MSPR 0.00%

MSPRV -11.57%

MSPRW 0.00%

MSPRZ 0.00%

MTBC 12.19%

MTBCO 0.16%

MTBCP -0.28%

ONMD -1.75%

OTRKP 10.34%

PEARW 0.00%

SHCRW -3.26%

SHLT -5.62%

Insider Trading

Date	Person	Action	Amount	type
2023-03-28	Thramann Jeffrey John	Sell	1	Series A Preferred Stock
2023-02-16	Thramann Jeffrey John	Buy	1	Series A Preferred Stock
2022-12-29	Ness Brent	Buy	7 711	Common Stock
2022-12-29	Ness Brent	Buy	8 500	Common Stock
2022-12-28	Ness Brent	Buy	2 289	Common Stock

INSIDER POWER
-64.09
Last 11 transactions
Buy: 256 033 \| Sell: 1 244 023

Correlation (AI algo v.1.1b): Undervalued: 0.01% $0.0365 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Aclarion, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aclarion, Inc. Financials

Annual	2023
Revenue:	$75 404.00
Gross Profit:	$-162 995 (-216.16 %)
EPS:	$-8.82

FY	2023
Revenue:	$75 404.00
Gross Profit:	$-162 995 (-216.16 %)
EPS:	$-8.82

FY	2022
Revenue:	$60 444.00
Gross Profit:	$-4 854.00 (-8.03 %)
EPS:	$-23.88

FY	2021
Revenue:	$60 292.00
Gross Profit:	$-8 883.00 (-14.73 %)
EPS:	$0

Financial Reports:

No articles found.

Aclarion, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Aclarion, Inc.

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.